Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for August 2011
August 1, 2011
- NanoViricides Expands On Prior HIVCide Effectiveness Release
- Results of Phase III BRAVO Trial Reinforce Unique Profile of Laquinimod for Multiple Sclerosis Treatment
- Bendavia Presented at 2011 American Heart Association's Cardiovascular Scientific Sessions
- Can Opioids Become a Friend for Life?
August 2, 2011
- Oncolytics Biotech Inc. Announces Publication of Preclinical Research on Synergistic Combination of Chemotherapy with Oncolytic Virotherapy
- Jennerex Reports Positive Mechanistic Proof-of-Concept Clinical Trial Results Using JX-594 to Treat Metastatic Melanoma
- Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
- CytRx's INNO-206 in Combination Therapy Induces Complete Remissions in Aggressively Growing Ovarian Cancer Tumor Model
- NIH Awards $84 Million Grant to NYU Langone Medical Center and Partnering Institutions for First-of-Its-Kind Comparative Effectiveness ISCHEMIA Clinical Trial
August 3, 2011
- Amarantus BioSciences Presents Summary of Peer-Reviewed Data for Parkinson's Program
- Actelion's selective S1P1 receptor agonist ponesimod successful in mid-stage trial for multiple sclerosis - Ponesimod to proceed to Phase III final stage of clinical development
- Adverse Childhood Could Raise Adult Heart Disease Risk
- Use of Antipsychotics for Reducing Military-related Chronic PTSD Symptoms Does Not Appear Effective
August 4, 2011
- iBio Announces Malaria Vaccine Milestone Achievement on its iBioLaunch Platform
- Antares Pharma Announces Positive Study Results with VIBEX MTX in Rheumatoid Arthritis Patients
- YM BioSciences JAK Inhibitor CYT387 Shown Active in Multiple Myeloma
- Roche?s Investigational Treatment for Asthma Met Its Primary Endpoint in A Phase II Study
- PROLOR Biotech Announces Positive Top-Line Results From Phase II Trial of its Long-Acting Human Growth Hormone That Achieved All Key Study Goals
- Johnson & Johnson Pharmaceutical Research & Development Scientists Uncover Previously Unknown Role for Class of Molecules
- Children's Hospital Los Angeles Researchers Define Key Protein Components Involved in Lung Repair
August 5, 2011
- Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
- A Patient's Own Skin Cells May One Day Treat Multiple Diseases
- More Neurology Residents Comfortable Using Stroke Clot-busting Drug
- Antares Pharma Announces Positive Study Results With Vibex Mtx in Rheumatoid Arthritis Patients
- Oxford BioMedica Announces Interim Data from Highest (5x) Dose Cohort in ProSavin Phase I/II Study in Parkinson's Disease
- Molecular Mechanisms Offer Hope for New Pain Treatments
- UCLA Study Shows Man-made Fat May Limit Damage to Heart Attack Victims
August 8, 2011
- Texas Scottish Rite Hospital for Children (TSRHC) Researchers Discover Genes Associated with Idiopathic Scoliosis
- Fine-tuning the Flu Vaccine for Broader Protection
August 9, 2011
- Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
- Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis
- Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
- Genmab Announces Top-Line Phase Ii Results for Ofatumumab Combined With Chemotherapy in Second Line Aggressive Lymphoma
- Phase 2 Trial of Lexicon's LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
August 10, 2011
- Omega-3 Fatty Acids Show More Cardiovascular Benefits and May Reduce Risk of Preterm Delivery and Chronic Kidney Disease
- Two Gencaro Atrial Fibrillation Abstracts Accepted for Presentation at the American Heart Association Scientific Sessions 2011
- Adolor Corporation Announces Positive Results from Phase 2 Program in OIC
August 11, 2011
- Stroke Prevention in Patients with Atrial Fibrillation: New England Journal of Medicine Publishes Results of ROCKET AF Study of Bayer's rivaroxaban
- Lexicon Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
- Newly-Published Colchicine Safety Data Provide First Evidence-Based Dosing Guidance to Avoid Potentially Serious Interactions With Commonly Prescribed Drugs
August 12, 2011
- Scientists Identify Mutation in SIGMAR1 Gene Linked to Juvenile ALS
- Depression Linked to Increased Risk of Stroke in Women
- Common Class of Pain Drugs Reduces Severity of Postpartum Breast Cancers
- New Research Explains how Estrogen Could Help Protect Women from Cardiovascular Disease
August 15, 2011
- Gilead's Investigational Antiretroviral Quad Regimen Meets 48-Week Primary Objective in Pivotal Phase 3 Clinical Study 102
- NanoViricides Reports HIVCide Exhibited Long Term Sustained Anti-HIV Effects Even After Drug Discontinuation
- Impax and GSK Announce Positive Topline Results of ASCEND-PD Phase III Study of IPX066 in Advanced Parkinson's Disease
- Effient (Prasugrel) Showed Significant 26 Percent Reduction in Cardiovascular Events Over Clopidogrel in New Core Clinical Cohort Population Sub-Analysis of the TRITON-TIMI 38 Pivotal Study
- Childhood Eye Tumor Made Up of Hybrid Cells with Jumbled Development
August 16, 2011
- Novel Flavonoid Compounds That Significantly Reduce Cancer Cell Growth Are Available For Further Research and Development as Anti-Cancer Therapeutics
- New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses
- Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receiving Concomitant Antibiotics
- Defect in A20 Gene Expression Causes Rheumatoid Arthritis
- NexBio Reports Safety and Significant Antiviral Activities of DAS181 (Fludase)* from a Dose-Ranging Phase II Clinical Trial
- Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's Genous Stent in Patients at High Risk for Restenosis
August 17, 2011
- New Survey Reports Some Postmenopausal Women Endure Vaginal and Sexual Symptoms of Menopause for More Than Two Years before Discussing with Health Care Professional
- Journal Republishes the 1996 Landmark Report That Set the Research Strategy for HIV/AIDS
- Savient Pharmaceuticals Announces Publication of Pivotal Phase III Krystexxa Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients
August 18, 2011
- AIDS Researchers Isolate New Potent and Broadly Effective Antibodies Against HIV
- Clavis Pharma announces encouraging interim results of Phase II trial with elacytarabine in combination with idarubicin in patients with early stage acute myeloid lymphoma (AML)
- Basilea reports financial results for the first half-year 2011
- Scientists Show how Gene Variant Linked to ADHD Could Operate
- HIV Havens: Caltech Researchers Find New Clues about How HIV Reservoirs may Form
- Gladstone Scientist Identifies Gene that Exacerbates Risk Factors for Heart Disease and Diabetes
- Generex Subsidiary Antigen Express Provides Update on Phase 2 Breast Cancer Immunotherapy Program
August 19, 2011
- Malaria Parasites Camouflage Themselves from the Immune Defenses of Expectant Mothers
- Acne-treating Antibiotic Cuts Catheter Infections in Dialysis Patients
- Strengthening Fragile Immune Memories to Fight Chronic Infections
- SUNY Downstate Researchers Identify Possible New Targets for Treating Pain in Women
August 22, 2011
- Stanford Study Draws Connection Between Narcolepsy and Influenza
- Major ALS Breakthrough
- New Defense Discovered Against Common Hospital-acquired Infection
August 23, 2011
- Bristol-Myers Squibb And Pfizer Announce Data Presentations For Apixaban At European Society of Cardiology Congress 2011
- Aeterna Zentaris to Present Poster on Novel Oral Anticancer Erk Inhibitors at Upcoming American Chemical Society's National Meeting
- Bronchodilation in asthmatics maintained with daily dosing of RPL554
- Metabolon Study Provides Insight Into Acrolein-Induced Lung Injury
August 24, 2011
- Prestigious Molecular Biology Journal Publishes Breakthrough Research Led by Dr. Andres Tellez: Milestone Achievement Reflects Robust Brain Trust at Biocodex USA
- FREEDOM-C(2) Trial of Oral Treprostinil in Pulmonary Arterial Hypertension Does Not Meet Primary Endpoint
- Stay in ICU Means Fewer Patients Likely to Renew Prescriptions After Discharge
- TGen and DTU Researchers Track Source of Haitian Cholera Outbreak
- Deaths from Strong Prescription Painkillers are on the Increase
- Exercise Can Substitute Effectively as Second 'medication' for People with Depression
- HIV Experts Create the Roadmap for Providing PrEP to Uninfected Individuals to Reduce the Risk of HIV Infection
- NanoBio's Intranasal RSV Vaccine Induces Robust Immunity in Animals
- Researchers Find "Key" Used by Ebola Virus to Unlock Cells and Spread Deadly Infection
- Obagi Medical Products Announces Publication of Study in the July Edition of the Aesthetic Surgery Journal
August 25, 2011
- Top-Line Results from Pivotal Trial of Dermagraft for Venous Leg Ulcers
- New Study Finds Fewer than Half of Female Teens Have Been Vaccinated for HPV, Thousands of Women Develop Cancer Needlessly: Reaction Statement from TFAH
August 26, 2011
- Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax Vaccine Published in the Journal Vaccine
- Cell Receptor Could Allow Measles Virus to Target Tumors
- Why HIV Virus Infection Rates Are on the Rise
August 29, 2011
- Stroke Prevention Therapy Use Low Among High-Risk Patients With Atrial Fibrillation (AF)
- ELIQUIS (apixaban) was Superior to Warfarin for the Reduction of Stroke or Systemic Embolism with Significantly Less Major Bleeding in Patients with Atrial Fibrillation in Phase 3 ARISTOTLE Trial
- New Data Underscores Importance of Platelet Reactivity Testing to Aid in Risk Assessment
- Curemark Reports Positive Results for Novel Compound CM-182 in Amphetamine Induced Hyperactivity
August 30, 2011
- Aeterna Zentaris Announces Results of its Novel Orally Active Anticancer Erk Inhibitor at the American Chemical Society National Meeting
- Results of Phase III Study for Perampanel Presented at 2011 International Epilepsy Congress
- Bionovo Announces Positive Results of the Tolerability Trial of Menerba (MF101) for Menopausal Hot Flashes
- New Study Demonstrates Effectiveness of Extracorporeal Photopheresis in Early-Stage Cutaneous T-Cell Lymphoma
- Actelion reports results of exploratory study with macitentan in IPF patients - promising long-term safety and tolerability profile - efficacy data not supportive of Phase III in IPF
- MOLOGEN AG: First evaluation data on clinical trial with MGN1601 ? results for renal cancer therapy considerably better than anticipated
- Clearance of Sunshine Biopharma's anti-cancer compound, Adva-27a, does not involve a toxic intermediate
- QLT Shows Positive 4 Week Efficacy in Phase II Study for Glaucoma Using Latanoprost Punctal Plug Delivery System
- Peregrine Reports Promising 20.7 Month Median Overall Survival From Phase II Advanced Breast Cancer Trial
- Safety and tolerability of the oral Xa inhibitor darexaban for secondary prevention after acute coronary syndromes
- Zertane Clinical Results Published in the Journal European Urology
August 31, 2011
- NexBio's DAS181 (Fludase) Improves Symptoms in Four Severely Immunocompromised Patients With Life-Threatening Parainfluenza Pneumonitis
- Shire Presents Positive Data from Fabry and Gaucher Disease Studies that Continue to Support Patient Switches to Replagal (agalsidase alfa) and Vpriv (velaglucerase alfa)
- Jennerex Publishes Clinical Data in Journal, Nature, Demonstrating Intravenous Delivery of Multi-Mechanistic Cancer-Targeted Oncolytic Poxvirus JX-594 to Tumors
